{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083214","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.915673+00:00","generated_at":"2026-05-19T19:27:44.579615+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Achieve Life Sciences shareholders reject director equity plan increase","bullets":["All seven director nominees elected with majority 'for' votes; broker non-votes 11,422,484.","Ratification of PwC as auditor for FY2025 approved: 26,459,791 for, 53,879 against.","Amendment to 2023 Non-Employee Director Equity Incentive Plan to increase shares failed: 6,736,105 for, 7,982,633 against.","Proposal required majority of votes cast; failure may impact director compensation strategy.","Broker non-votes (11,422,484) were not counted on non-routine matters, effectively against the plan."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083214","json":"https://secwatch.observer/filing/0000950170-25-083214.json","markdown":"https://secwatch.observer/filing/0000950170-25-083214.md","text":"https://secwatch.observer/filing/0000950170-25-083214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000095017025083214/0000950170-25-083214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000095017025083214/achv-20250604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T19:27:44.579615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}